The use of pramipexole in Parkinson's disease: are its actions D(3) mediated?

Parkinsonism & Related Disorders
M Guttman, J Jaskolka

Abstract

Pramipexole is a non-ergot dopamine agonist recently approved for the treatment of early and advanced Parkinson's disease (PD). It has preferential affinity for the D(3) dopamine receptor, compared to previous dopamine agonists that have higher affinity for D(2) dopamine receptors. The ultimate question is whether its efficacy is linked to its action at the D(3) dopamine site or due to its binding to D(2) dopamine receptors. There is no direct experimental evidence available to answer this question. Based on a review of the pharmacological literature, it is likely that the motor benefits of pramipexole in PD patients are due to D(2) stimulation, whereas its putative effects on mood and apathy may be related to its D(3) agonist properties.

References

Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·S RuggieriA Agnoli
Jan 1, 1985·Journal of Neural Transmission·M Guttman, P Seeman
May 1, 1986·Annals of Neurology·M GuttmanW W Tourtellotte
Jun 23, 1995·European Journal of Pharmacology·J MierauR M Huff
Mar 4, 1995·BMJ : British Medical Journal·N Quinn
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·C W OlanowJ Jankovic
Sep 30, 1993·The New England Journal of Medicine·D B Calne
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·R BordetJ C Schwartz
Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·H L RyooJ N Joyce
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Oct 15, 1998·The New England Journal of Medicine·A E Lang, A M Lozano

❮ Previous
Next ❯

Citations

Aug 9, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·O ChernolozP Blier
Aug 22, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M R Lemke
Aug 22, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J C MöllerW H Oertel
Oct 4, 2011·Internal Medicine·Akihiko MoritaKoichi Hirata
Dec 22, 2005·Acta Neurologica Scandinavica·A Lieberman
Jan 23, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Carsten BuhmannMatthias Oechsner
Oct 28, 2015·Practical Neurology·Biba R Stanton, Alan Carson
Sep 20, 2006·Clinical Therapeutics·Trond KvernmoErich Burger
Aug 25, 2007·Annual Review of Clinical Psychology·W John Livesley, Kerry L Jang
Dec 31, 2003·Journal of Speech, Language, and Hearing Research : JSLHR·Judy F FlaxPaula Tallal
Jun 30, 2009·Journal of the American Medical Directors Association·Shinya IshiiJames R Mervis

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.